| Literature DB >> 33330608 |
Yilong Fu1, Mengwei Wu2, Jinbo Fu1, Suqiong Lin1, Zhengfu Song1, Jiyu Chen1, Wei Yan1, Penghao Kuang1, Fusheng Lin1, Yezhe Luo1, Ende Lin1, Xiaoquan Hong1, Guoyang Wu1.
Abstract
Purpose: Transoral endoscopic thyroidectomy via vestibular approach (TOETVA), with its excellent cosmetic effect, has become increasingly popular worldwide. Nonetheless, anatomic obstacles have limited its development to a certain extent. Here, we present our preliminary outcomes of transoral endoscopic thyroidectomy via submental and vestibular approach (TOETSMVA), which can overcome those limitations.Entities:
Keywords: submental approach; thyroid; thyroidectomy; transoral; vestibular approach
Year: 2020 PMID: 33330608 PMCID: PMC7719628 DOI: 10.3389/fsurg.2020.591522
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Figure 1(A) The visible subcutaneous stripper; (B) The first operative space.
Figure 2(A) CO2 insufflation and surgical sutures were used to maintain the operating space; (B) Two 5-mm trocars were inserted.
Figure 3The external branch of superior laryngeal nerve of left side (yellow arrow).
Figure 4Superior parathyroid gland of left side (yellow arrow).
Figure 5The right side ipsilateral central lymph node dissection was finished. CCA, common carotid artery; RLN, recurrent laryngeal nerve; superior parathyroid gland (yellow arrow); inferior parathyroid gland (red arrow).
Demographic data (n = 21).
| Female | 12(57.1%) |
| Male | 9(42.9%) |
| Age (mean ± SD) (years) | 37.5 ± 10.4 |
| BMI (mean ± SD) (kg/m2) | 22.6 ± 2.4 |
| Nodule size (mean ± SD) (cm) | 1.4 ± 1.3 |
| Maximum nodule size (cm) | 4.9 |
| Left | 11(52.4%) |
| Right | 10(47.6%) |
| Benign nodule | 5(23.8%) |
| PTMC | 14(66.7%) |
| PTC | 2(9.5%) |
| N0 | 8(50%) |
| N1a | 8(50%) |
BMI, body mass index; PTMC, papillary thyroid micro-carcinoma; PTC, papillary thyroid cancer.
Surgical outcomes (n = 21).
| Operation time (min) | 138 ± 33.2 |
| Hospital day (days) | 3.3 ± 0.8 |
| Intraoperative blood loss (mL) | 10.7 ± 6.1 |
| No. of total CLN in cancer patients | 5.2 ± 2.7 |
| No. of positive CLN in cancer patients | 1.3 ± 2.1 |
| Cutaneous paralysis in the center of chin region | 0(0%) |
| Transient recurrent laryngeal nerve paralysis | 1(4.8%) |
| Permanent recurrent laryngeal nerve paralysis | 0(0%) |
| Postoperative bleeding | 0(0%) |
| Infection | 0(0%) |
| Hypoparathyroidism | 0(0%) |
CLN, central lymph node.
Figure 6The postoperative picture of 3 months.